中国HPV疫苗上市后全国人群知识态度行为调查
2019年4月在中国大陆多阶段非随机抽样招募18-45岁人群,最终分析4000名女性(32.1±7.81岁)和1000名男性(31.8±7.96岁);结果显示HPV及疫苗认知知晓率低、知识得分差,仅3%女性接种过疫苗,但未接种者接种意愿较高;主要障碍为安全性担忧、知识缺乏和疫苗价格高。
要点
- 仅31%女性和22%男性听说过HPV,34%女性和23%男性听说过HPV疫苗。
- HPV知识得分女性3/13、男性1.8/13,疫苗知识女性3/6、男性2/5。
- 仅3%女性已接种HPV疫苗,但未接种者接种意愿较高。
核心结论
- 中国大陆一般人群HPV疫苗认知、知识及接种率均低,需开展健康教育以加速疫苗推广。
研究设计与样本
- 2019年4月在中国大陆以多阶段非随机抽样招募18-45岁居民,最终分析4000名女性和1000名男性,问卷评估社会人口学因素、HPV及疫苗认知知识态度、接种情况和障碍,采用双变量分析和多因素回归识别差异。
主要发现
- 听说过HPV者女性31%、男性22%,听说过HPV疫苗者女性34%、男性23%。
- HPV知识得分女性3/13、男性1.8/13,HPV疫苗知识得分女性3/6、男性2/5。
- 仅3%女性已接种三剂HPV疫苗,未接种者接种意愿平均分女性3.3±0.97、男性3.0±0.98。
- 就业行业和家庭收入是与疫苗认知和知识相关的主要因素,HPV及疫苗知晓是接种意愿的关键影响因素。
- 接种主要障碍为安全性担忧、知识缺乏和HPV疫苗价格高。
关键数值与推荐
- 最终分析样本:4000名女性(32.1±7.81岁)和1000名男性(31.8±7.96岁)。
- 知晓率:HPV女性31%、男性22%;HPV疫苗女性34%、男性23%。
- 知识得分:HPV女性3/13、男性1.8/13;HPV疫苗女性3/6、男性2/5。
- 接种率:仅3%女性已接种HPV疫苗。
- 未接种者接种意愿平均分:女性3.3±0.97、男性3.0±0.98。
临床怎么用
- 应针对低知晓、低知识人群开展健康教育,重点传递HPV及疫苗相关知识。
- 关注就业行业和家庭收入差异,针对重点人群缩小认知差距。
- 针对安全性担忧、知识缺乏和价格高三大障碍设计干预措施以提升接种率。
局限性
- 采用多阶段非随机抽样,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) vaccine has been increasingly discussed in mainland China since its first approval in 2016. To date, nearly all studies assessing HPV vaccine perceptions and attitudes were implemented during pre-licensure period. Therefore, the nationwide post-marketing survey was conducted to update knowledge, attitudes and practice on HPV vaccine among general population in mainland China. METHODS: Participants aged 18-45 years living in mainland China were recruited in April 2019 by multi-stage non-randomized sampling. Sociodemographic factors, HPV and HPV vaccine related awareness, knowledge, attitudes, vaccine uptake and potential obstacles were assessed in questionnaires. Bivariate analysis and multivariate regression were used to identify disparity among subgroups with different sociodemographic characteristics. RESULTS: 4,000 women (32.1 ± 7.81y) and 1,000 men (31.8 ± 7.96y) were included in final analysis. Less than one third of participants had heard of HPV (female: 31%; male: 22%) and HPV vaccine (female: 34%; male: 23%). Knowledge score was also unfavorable on HPV (female: 3 out of 13; male: 1.8 out of 13) and HPV vaccine (female: 3 out of 6; male: 2 out of 5). Only 3% females had been vaccinated three years after HPV licensure in China, although willingness to get vaccinated among those unvaccinated were high (mean willingness score ± SD: female: 3.3 ± 0.97; male: 3.0 ± 0.98). Industry of employment and household income were the major factors related to awareness and knowledge of vaccine, whereas HPV and HPV vaccine awareness were key influential factors for willingness. The main obstacles of vaccination were safety concerns, lack of knowledge, and high price of HPV vaccines. CONCLUSIONS: Findings highlight a lack of vaccine awareness, knowledge, and poor uptake in mainland China and underscore the necessity of health education campaigns. The identified priority groups, contents to be delivered and practical obstacles could furthermore provide insight into health education to reduce disparities and accelerate HPV vaccine roll-out in China.
引用
- Hu S, Xu X, Zhang Y, et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China. Vaccine. 2020. PMID: 33243631. doi:10.1016/j.vaccine.2020.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。